Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Skin irritation: the substance does not cause skin irritation based on OECD TG 439

Eye irritation: not irritant based on OECD TG 438

The substance is not a skin or eye irritant and therefore it is not likely to be a respiratory irritant

Key value for chemical safety assessment

Skin irritation / corrosion

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Eye irritation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Respiratory irritation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Additional information

Skin irritation


Skin irritating properties of the substance were tested in an in vitro skin irritation test using the EpiDerm(TM) reconstructed skin membranes (OECD TG 439) and in compliance with GLP. Skin tissue was exposed to 30 μL of test material for 60 min, washed, incubated in medium for 42 hours and then examined for viability by the MTT assay. Phosphate-buffered saline and 5% sodium dodecyl sulphate were used as positive and negative control, respectively. Mean tissue viability of the positive control was 4%. Tissue viability following exposure to the substance was 87± 8% (mean ± SD) compared to the negative control. As this value was above the limit value of 50%, the substance was considered to be non-irritating to human skin.


Eye irritation


The eye irritating properties of the substance were tested in vitro, in an Isolated Chicken Eye (ICE) test according to OECD TG 438 and in compliance with GLP. The test included a negative control (saline) and a positive control (5% benzalkonium chloride). The isolated chicken eyes were treated with of 30 μL of the substance for 10 seconds and then rinsed with 20 mL saline. Corneal swelling, corneal opacity and fluorescein retention were measured to disclose possible adverse effects. The substance caused no swelling of the cornea (0%), slight corneal opacity (score 1 out of max. 4) and slight fluorescein retention (score 1 out of max.3). The corresponding irritation categories were I, II and II, respectively. The irritation index (calculated as maximum corneal swelling + maximum mean opacity (x 20) + mean fluorescein score (x 20)) was 40 (out of max. 200). The positive control produced moderate corneal swelling (29%), severe opacity (score 3.0) and severe fluorescein retention (score 3.0). The calculated irritation index was 149. Based on the results of this in vitro study, the substance is considered not irritating to the eye.


Respiratory irritation:


For respiratory irritation mostly human data are used for the assessment because no suitable in vitro or in vivo tests are available that can identify respiratory irritation (REACH guidance R.7.2.3). There are no human data such as indicated in R7.2.3 of the ECHA guidance that indicate respiratory reactions of the substance e.g. from consumer experience or occupational exposure. In addition, the substance is not corrosive or severely irritating which further minimizes the respiratory irritation hazard (REACH guidance: 7.2.1.2).

Justification for classification or non-classification

Based on the negative results of the available studies, classification of the substance for skin, eye or respiratory irritation is not warranted according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.